The role of circulating tumor DNA in ovarian cancer
Yiliminuer Abulajiang, Wang Ming, Yumei Wu · 2026
Read The role of circulating tumor DNA in ovarian cancer by Yiliminuer Abulajiang, Wang Ming, Yumei Wu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13451178.txt.
Description
Yiliminuer Abulajiang and others took stock of tumor DNA in blood for ovarian cancer in 2026, weighing its use as a liquid biopsy. Ovarian cancer is one of the deadliest female cancers, and early finds are hard. Tumor DNA shed in blood might flag disease, track small leftovers, foretell relapse, and steer bespoke care.
The review covers early screening, leftover tracking, relapse foretelling, and care choice, setting tumor DNA next to old markers on hit rate and true rate. It also weighs live limits: weak finds in early disease and no set test norms. Next work should hone test methods and join tumor DNA with other markers. Doctors gain a fair view of a bright but not yet routine tool.
Catalog record
| CREATOR | Yiliminuer Abulajiang, Wang Ming, Yumei Wu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 102 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |